Stockreport

Skye Bioscience to Announce Third Quarter 2024 Results

Skye Bioscience, Inc.  (SKYE) 
PDF SAN DIEGO, Nov. 01, 2024 (GLOBE NEWSWIRE) -- Skye Bioscience, Inc. (Nasdaq: SKYE) (“Skye”), a clinical-stage biopharmaceutical company focused on unlocking new therape [Read more]